 |
|
| Session III: Medical
Genomics and Pharmacogenomics |
|
|
| <April. 28 (Wed.) 1999> |
|
| |
Dr. Daniel Cohen
(GENSET SA)
Genome Wide Linkage Disequilibrium Mapping in Humans |
(Page 24) |
|
|
|
| |
Prof.
Graeme I. Bell (University of Chicago)
Genetics Studies of Diabetes Mellitus and Drug Discovery |
(25) |
|
|
|
| |
Dr. Mark H. Pausch
(American Cyanamid Company)
GPCRs Expressed in Yeast: HTS Assays for Drug Discovery |
(26) |
|
|
|
| |
Prof. Toshio Tanaka
(Mie University)
Therapeutic Target Validation and Pharmacogenomics |
(27) |
|
|
|
|
Prof. Yasushi Yamazoe
(Tohoku University)
Individual Difference and Genetic Polymorphism of Drug Metabolizing
Enzymes in Human |
(28) |
|
|
